Literature DB >> 31690899

A consensus protocol for the in silico optimisation of antibody fragments.

Miguel A Soler1, Barbara Medagli, Marta S Semrau, Paola Storici, Gregor Bajc, Ario de Marco, Alessandro Laio, Sara Fortuna.   

Abstract

We present an in silico mutagenetic protocol for improving the binding affinity of single domain antibodies (or nanobodies, VHHs). The method iteratively attempts random mutations in the interacting region of the protein and evaluates the resulting binding affinity towards the target by scoring, with a collection of scoring functions, short explicit solvent molecular dynamics trajectories of the binder-target complexes. The acceptance/rejection of each attempted mutation is carried out by a consensus decision-making algorithm, which considers all individual assessments derived from each scoring function. The method was benchmarked by evolving a single complementary determining region (CDR) of an anti-HER2 VHH hit obtained by direct panning of a phage display library. The optimised VHH mutant showed significantly enhanced experimental affinity with respect to the original VHH it matured from. The protocol can be employed as it is for the optimization of peptides, antibody fragments, and (given enough computational power) larger antibodies.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31690899     DOI: 10.1039/c9cc06182g

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  11 in total

1.  Multiple-Allele MHC Class II Epitope Engineering by a Molecular Dynamics-Based Evolution Protocol.

Authors:  Rodrigo Ochoa; Victoria Alves Santos Lunardelli; Daniela Santoro Rosa; Alessandro Laio; Pilar Cossio
Journal:  Front Immunol       Date:  2022-04-27       Impact factor: 8.786

2.  Computational Evolution of Beta-2-Microglobulin Binding Peptides for Nanopatterned Surface Sensors.

Authors:  Abimbola Feyisara Adedeji Olulana; Miguel A Soler; Martina Lotteri; Hendrik Vondracek; Loredana Casalis; Daniela Marasco; Matteo Castronovo; Sara Fortuna
Journal:  Int J Mol Sci       Date:  2021-01-15       Impact factor: 5.923

3.  Effect of Humanizing Mutations on the Stability of the Llama Single-Domain Variable Region.

Authors:  Miguel A Soler; Barbara Medagli; Jiewen Wang; Sandra Oloketuyi; Gregor Bajc; He Huang; Sara Fortuna; Ario de Marco
Journal:  Biomolecules       Date:  2021-01-26

4.  Delicate balance among thermal stability, binding affinity, and conformational space explored by single-domain VHH antibodies.

Authors:  Emina Ikeuchi; Daisuke Kuroda; Makoto Nakakido; Akikazu Murakami; Kouhei Tsumoto
Journal:  Sci Rep       Date:  2021-10-18       Impact factor: 4.379

5.  Multiscale affinity maturation simulations to elicit broadly neutralizing antibodies against HIV.

Authors:  Simone Conti; Victor Ovchinnikov; Jonathan G Faris; Arup K Chakraborty; Martin Karplus; Kayla G Sprenger
Journal:  PLoS Comput Biol       Date:  2022-04-20       Impact factor: 4.779

Review 6.  Recombinant expression of nanobodies and nanobody-derived immunoreagents.

Authors:  Ario de Marco
Journal:  Protein Expr Purif       Date:  2020-04-11       Impact factor: 1.650

Review 7.  Toward Drug-Like Multispecific Antibodies by Design.

Authors:  Manali S Sawant; Craig N Streu; Lina Wu; Peter M Tessier
Journal:  Int J Mol Sci       Date:  2020-10-12       Impact factor: 5.923

8.  Native llama Nanobody Library Panning Performed by Phage and Yeast Display Provides Binders Suitable for C-Reactive Protein Detection.

Authors:  Sandra Oloketuyi; Robert Bernedo; Andreas Christmann; Justyna Borkowska; Giulia Cazzaniga; Horst Wilhelm Schuchmann; Joanna Niedziółka-Jönsson; Katarzyna Szot-Karpińska; Harald Kolmar; Ario de Marco
Journal:  Biosensors (Basel)       Date:  2021-12-03

9.  CDR1 Composition Can Affect Nanobody Recombinant Expression Yields.

Authors:  Marco Orlando; Sara Fortuna; Sandra Oloketuyi; Gregor Bajc; Adi Goldenzweig; Ario de Marco
Journal:  Biomolecules       Date:  2021-09-14

10.  Research Progress and Applications of Multivalent, Multispecific and Modified Nanobodies for Disease Treatment.

Authors:  Jiewen Wang; Guangbo Kang; Haibin Yuan; Xiaocang Cao; He Huang; Ario de Marco
Journal:  Front Immunol       Date:  2022-01-18       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.